133 related articles for article (PubMed ID: 7727857)
1. [Resistance and resistances].
Cappelaere P
Bull Cancer; 1994 Dec; 81 Suppl 2():115s-117s. PubMed ID: 7727857
[TBL] [Abstract][Full Text] [Related]
2. Intrinsic and acquired drug resistance in malignant tumors. The main reason for therapeutic failure.
Lippert TH; Ruoff HJ; Volm M
Arzneimittelforschung; 2008; 58(6):261-4. PubMed ID: 18677966
[TBL] [Abstract][Full Text] [Related]
3. Intrinsic versus acquired drug resistance.
Mackillop WJ
Cancer Treat Rep; 1986 Jun; 70(6):817-8. PubMed ID: 3731144
[No Abstract] [Full Text] [Related]
4. The reversal of multidrug resistance in cancer (review).
Kellen JA
Anticancer Res; 1993; 13(4):959-61. PubMed ID: 8352566
[TBL] [Abstract][Full Text] [Related]
5. [From the research laboratory to the clinical laboratory: reflections on the transfer of technology about drug resistance].
Favre R
Bull Cancer; 1994 Dec; 81 Suppl 2():112s-114s. PubMed ID: 7727856
[TBL] [Abstract][Full Text] [Related]
6. Multidrug resistance: clinical relevance in solid tumours and strategies for circumvention.
Kaye SB
Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S15-9. PubMed ID: 9801854
[TBL] [Abstract][Full Text] [Related]
7. Resistance to chemotherapy in cancer: a complex and integrated cellular response.
Mellor HR; Callaghan R
Pharmacology; 2008; 81(4):275-300. PubMed ID: 18259091
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of drug resistance.
Longley DB; Johnston PG
J Pathol; 2005 Jan; 205(2):275-92. PubMed ID: 15641020
[TBL] [Abstract][Full Text] [Related]
9. Transcription factors and drug resistance.
Kohno K; Uchiumi T; Niina I; Wakasugi T; Igarashi T; Momii Y; Yoshida T; Matsuo K; Miyamoto N; Izumi H
Eur J Cancer; 2005 Nov; 41(16):2577-86. PubMed ID: 16209921
[TBL] [Abstract][Full Text] [Related]
10. [Resistance, the cause of failure in antineoplastic chemotherapies].
Israel L
Pathol Biol (Paris); 1989 Feb; 37(2):125-7. PubMed ID: 2652060
[No Abstract] [Full Text] [Related]
11. Cancer chemotherapy 1990.
Bagshawe KD
Trans Med Soc Lond; 1989-1990; 106():42-50. PubMed ID: 2562620
[No Abstract] [Full Text] [Related]
12. [Antineoplastic drugs: resistance and metabolism].
Lavigne JG
Union Med Can; 1976 Feb; 105(2):186-8. PubMed ID: 996993
[No Abstract] [Full Text] [Related]
13. The effect of intrinsic and acquired resistances on chemotherapy effectiveness.
Menchón SA
Acta Biotheor; 2015 Jun; 63(2):113-27. PubMed ID: 25750013
[TBL] [Abstract][Full Text] [Related]
14. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
Schmidt W; Chaney SG
Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361
[TBL] [Abstract][Full Text] [Related]
15. Cancer chemotherapy.
McElwain TJ
Clin Oncol; 1980 Mar; 6(1):85-6. PubMed ID: 7371238
[No Abstract] [Full Text] [Related]
16. Molecular interrelationships in multidrug resistance (review).
Kellen JA
Anticancer Res; 1994; 14(2A):433-5. PubMed ID: 8017843
[TBL] [Abstract][Full Text] [Related]
17. [Cell resistance in oncology. Therapeutic prospects].
Rosso R; Guglielmi A; Aschele C; Mori A; Tixi L; Bolli E; Sobrero A
G Ital Chemioter; 1991; 38(1-3):95-7. PubMed ID: 1365622
[No Abstract] [Full Text] [Related]
18. Drug resistance in cancer therapy.
Cancer Treat Res; 1989; 48():1-203. PubMed ID: 2577132
[No Abstract] [Full Text] [Related]
19. Present status of chemosensitivity assays.
Kern DH; Bertelsen CA
Int Adv Surg Oncol; 1984; 7():187-213. PubMed ID: 6469373
[No Abstract] [Full Text] [Related]
20. Multidrug resistance.
Shibata H; Kanamaru R; Sato T; Ishioka C; Suzuki T; Wakui A
Sci Rep Res Inst Tohoku Univ Med; 1990 Dec; 37(1-4):27-50. PubMed ID: 2103657
[No Abstract] [Full Text] [Related]
[Next] [New Search]
